A61M15/0045

Manifold
20230347079 · 2023-11-02 ·

In general terms the present invention proposes a manifold 100 for delivery of medicament powder from a dispenser device. The manifold 100 comprises a first chamber 102 comprising a first chamber inlet 102A and a first chamber outlet 102B. The first chamber 102 is arranged to direct a first flow of air 110 from the first chamber inlet 102A to the first chamber outlet 102B. The manifold 100 also comprises a conduit 104 having a conduit inlet 104A and a conduit outlet 104B. The first chamber outlet 102B and conduit inlet 104A are arranged such that when a supply of medicament powder is positioned proximal thereto the first flow of air 110 is directed from the first chamber outlet 102B to the conduit inlet 104A via the supply of medicament powder to entrain the medicament powder and provide a flow of air entrained with medicament powder through the conduit 104. The manifold 100 has a bleed inlet 106 in a wall of the conduit 104 outside of the first chamber 102 arranged to direct a second flow of air 112 into the conduit 104 to disruptively impact the flow of air entrained with medicament powder through the conduit 104.

[FIG. 1C]

INHALATION DEVICE
20230347078 · 2023-11-02 ·

The present invention provides for the integration of drug dispersion methods into a drug or medicine delivery system. The drug dispersion methods used include shear (e.g., air across a drug, with or without a gas assist), capillary flow or a venturi effect, mechanical means such as spinning, vibration, or impaction, and turbulence (e.g., using mesh screens, or restrictions in the air path). These methods of drug dispersion allow for all of the drug in the system to be released, allowing control of the dosage size. These methods also provide for drug metering, fluidization, entrainment, deaggragation and deagglomeration. The present invention also provides for the integration of a drug sealing system into the device. The drug sealing system provides a way of blocking the migration of drug from one area of the package to another. The drug seal system can also provide a method of tightly containing the drug until the package is opened, of directing airflow through the package and of managing and containing the drug during the package/device manufacturing process.

Treating inflammation with inhaled aspirin
11819569 · 2023-11-21 · ·

The subject technology relates generally to pulmonary delivery of NSAIDs, such as aspirin.

Smoking device
11717027 · 2023-08-08 · ·

Apparatus and methods are described for use with a portion of plant material that includes at least one active ingredient. A vaporizing unit includes a heating element configured to heat the plant material, and a sensor configured to detect an indication of airflow rate through the vaporizing unit. Control circuitry is configured to receive an indication of the airflow rate through the vaporizing unit, and, in response thereto, to determine a smoking profile that is desired by the user. The control circuitry drives the heating element to vaporize the active ingredient of the plant material by heating the plant material according to the determined smoking profile. The control circuitry dynamically updates the smoking profile in response to changes in airflow rate over the course of a smoking session. Other applications are also described.

MEDICAMENT DELIVERY DEVICE

A medicament delivery device for dispensing discrete doses of medicament comprises: first and second medicament carriers each comprising said doses of medicament contained in a plurality of individual compartments spaced along a carrier strip and sealed by a sealing layer; first and second opening mechanisms each arranged to handle a respective one of the first and second medicament carriers and to open each compartment of the respective medicament carrier by separating the sealing layer from the carrier strip as the medicament carrier is advanced through the device; a take-up spool arranged to wind the separated sealing layers thereon such as to maintain the separated sealing layers in tension, each separated sealing layer having a path of travel between a respective one of the first and second opening mechanisms and the take-up spool; and a tension control element in contact with each of the separated sealing layers, wherein at least a part of the tension control element is arranged to be movable by a biasing force, which is exerted on the tension control element by the separated sealing layers as a result of any inequality in the tensions of the separated sealing layers wound by the take-up spool, to alter the length of the path of travel of each separated sealing layer so as to substantially equalise the tensions in the separated sealing layers.

Inhaler adapted to read information stored in data storage means of a container

The present disclosure relates to an inhaler adapted to supply a formulation comprised in a container to a user, the inhaler being adapted to read information stored in data storage means of the container. The present disclosure also relates to a system comprising such an inhaler and the container comprising the formulation, the container further comprising the data storage means storing the information. The present disclosure also relates to a container comprising a formulation, the container further comprising data storage means storing information, the container being adapted for supplying the formulation to a user, wherein the container is adapted for usage in an inhaler of any of the preceding claims. The disclosure also relates to set comprising the inhaler and a computing device external of the inhaler, wherein the inhaler and the computing device are adapted to communicate with each other. The disclosure also relates to the use of the inhaler, container, set and/or system for inhalation therapy.

FLOW REGULATING INHALER DEVICE

An inhaler device for pulmonary delivery of at least one substance from a drug dose cartridge to an inhaling user, including: a first conduit for conducting a carrier airflow to a proximal opening of a mouthpiece for use by the user; a holder configured to position the dose cartridge within the carrier airflow; and a second conduit for conducting a shunting airflow to the mouthpiece without passing through the dose cartridge position. In some embodiments, a controller connected to a valve controls a rate of carrier airflow, for example by controlling the shunting airflow, based on a sensor indication of airflow rate and a target airflow profile.

METHODS, DEVICES AND SYSTEMS FOR PULMONARY DELIVERY OF ACTIVE AGENTS
20220211958 · 2022-07-07 · ·

Provided herein is a method of pulmonary delivering to a subject at least one pharmacologically active agent being in a plant material, which is effected by pulmonary delivering the agent to the subject using a metered dose inhaler device that is configured to vaporize at least one pre-determined vaporized amount of the agent upon controllably heating the plant material, wherein the pre-determined vaporized amount is selected so as to achieve at least one pre-determined pharmacokinetic effect and/or at least one pre-determined pharmacodynamic effect induced by the agent in the subject.

METHOD AND DEVICE FOR VAPORIZATION AND INHALATION OF ISOLATED SUBSTANCES

A dose unit including at least one isolated bioactive agent applied on a carrier material in thermal contact with an electrically heating element configured to vaporize a pre-determined amount of the agent for pulmonary delivery thereof is provided herein, as well as devices for effecting vaporization and pulmonary delivery of the isolated agent, and methods for preparing the dose unit, controllably releasing the agent therefrom, methods for pulmonary delivery thereof and methods of treatment of medical conditions treatable by pulmonary delivery of the isolated bioactive agent.

Device and method for aerosolized delivery of substance to a natural orifice of the body
11278682 · 2022-03-22 · ·

A device for delivering a predetermined amount of a substance within at least one body cavity of a subject, where the predetermined amount is at an effective amount for treatment of obesity or binge eating disorder. The device includes (a) A volume to contain the predetermined amount of the substance. (b) A delivery end placeable in proximity to the body cavity. The delivery end is in fluid communication with the volume and comprises at least one orifice. (c) A valve mechanically connected to the volume, with at least two configurations: (i) an active configuration configured to deliver the predetermined amount of the substance; and, (ii) an inactive configuration, in which the valve prevents delivery of the predetermined amount of the substance. (d) A fluid tight chamber configured to contain a predetermined volume of pressurized gas at a predetermined pressure.